Solorank.ai
Login

Cached score snapshot

US.IQV · IQVIA

110分制 51.2/110；5D動能v2 5/50；排序分 56.2/160 · Incomplete inputs

Back to ranking Open volume snapshot
Ranking score 56.2/160
Main score 51.2/110
5D momentum v2 5/50
Rank #120
Setup grade F 27.7

Score breakdown

避免

Medium twelvedata

Score and price trend

F 27.7 Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 06-16 07-30 09-11 10-02 10-22 $150.53$235.31$320.09 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.297 · anchors 120 +2.03% -0.18% / +4.33% 70% 3.8% Actual outcome pending · 1 / 3 bars observed
30D observation +7.70% +1.29% / +14.74% 78.8% 10% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +1.19% -1.14% / +3.63% 61.9% 3.8% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-06-16 → 2026-10-22 · 119 archived points · 3 Improving turn signal · 8 Deteriorating signal · 2 Exit review signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 56.2
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 51.2/110 (避免)
5D momentum v2 5/50 (弱)
Score with momentum v2 56.2/160 (低排序)
Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 8 sections

Incomplete score

此 snapshot 已計出評分，但以下輸入仍不完整；缺失維度以 0 分處理，請留意 audit 明细。

  • VIX_MISSING: VIX market context is required for market environment scoring

Market inputs

Bar count 60
ma20 256.308
ma50 234.0474
close 257.3
prevClose 256.98
avgVolume20 1280570
volumeRatio 1.03
changePercent 0.12

Metrics snapshot

close 257.3
volume 1319291
changePercent 0.12

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 51.2/110
Main rating 避免
5D momentum v2 5/50
Score with momentum v2 56.2/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.5/5 · 較差
Dimension score 2.5/5
Dimension grade 較差

Sub-items

pbPoints 0.2
pePoints 0.2
epsPoints 0
roePoints 0.75
debtPoints 0.3
marginPoints 0
turnoverUsdM 339.4536
volumePoints 0.5
revenuePoints 0
dividendPoints 0
marketCapPoints 0.5

資金流 — 10.8/20 · 較差
Dimension score 10.8/20
Dimension grade 較差

Sub-items

cmfPoints 3.2
mfiPoints 0.8
obvPoints 0.8
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.IQV
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 6.2/15 · 較差
Dimension score 6.2/15
Dimension grade 較差

Sub-items

vix

score 0

details

source twelvedata+fred
missing true
vixClose n/a

trend

score 0.8

details

qqq

ma20 716.5275
ma50 710.6122
name QQQ
close 708.69
points 0.4

spy

ma20 767.5585
ma50 758.2458
name SPY
close 757.83
points 0.4
source twelvedata+fred
atrPct 2.6178
atrPoints 3
cciPoints 2.4
vixPoints 0
marketTrendPoints 0.8

催化劑 — 2/20 · 較差
Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 6
catalystCount 0
catalystPoints 2

風險管理 — 6.8/10 · 一般
Dimension score 6.8/10
Dimension grade 一般

Sub-items

position

score 1.6

details

atrPct 2.6178
turnoverUsdM 339.4536
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.IQV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 243.8286

strength_details

ma_score 1.5
atr_score 2
rsi_score 2
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 5.2
take_profit_price 272.4441
target_multiplier 1.9
technical_strength 1.78
take_profit_percent 5.9
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.2357
diversificationPoints 2

技術信號 — 18.9/30 · 一般
Dimension score 18.9/30
Dimension grade 一般

Sub-items

bbPoints 3
adxPoints 3
sarPoints 1.2
vcpPoints 2.2
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 2.2
vcp_reason 波幅收縮(17.4%→7.2%)；跌縮量(近10日4日)；站上MA50；Ready=Y；Confirm=N

vcp_metrics

up_days 3
vol_ref 1321793.3333
down_days 6
vcp_ready true
above_ma50 true
avg_vol_10 1370010
avg_vol_20 1257345
avg_vol_30 1321793.3333
range_pct_10 0.0724
range_pct_20 0.1478
range_pct_30 0.1735
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok true
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 1.0365
dist_to_20d_high 0.0533
down_shrink_days 4
breakout_level_20d 271.8
vcp_breakout_confirm false
contraction_ratio_10_30 0.4175
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0.4
shortMacdPoints 0.4
volConfirmPoints 0.6
volumePointsTechnical 1.2

情緒分析 — 4/10 · 較差
Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 6
negativeHits 0
positiveHits 2
sentimentScoreRaw 0.8

sentimentData

raw {"id":142064939,"url":"https://finnhub.io/api/news?id=7d100739ca55d9a6c112a7f2018fc42b45521cd237e053654c4be41a087a8b24","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"IQVIA Holdings has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.","category":"company","datetime":1789048609,"headline":"IQVIA Holdings Stock: Is IQV Outperforming the Health Care Sector?"}, {"id":141951092,"url":"https://finnhub.io/api/news?id=93848eb6afb610f535fc89a483e338126f7d28ee25855f7e15a50ffd125b29e4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"The past six months have been a windfall for IQVIA’s shareholders. The company’s stock price has jumped 50%, hitting $267.77 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.","category":"company","datetime":1788877878,"headline":"IQVIA (IQV): Buy, Sell, or Hold Post Q2 Earnings?"}, {"id":141364091,"url":"https://finnhub.io/api/news?id=d36cdb4e0d77330feac0b5cfd3ed05c727f0584ba3c9554ab81131400a40cfa0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its peers.","category":"company","datetime":1788213160,"headline":"Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment"}, {"id":141364092,"url":"https://finnhub.io/api/news?id=e062e495e00253d829c605d40440aad244c900a3d6cfcf9d0ecedb52f3f683d3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"Earlier in the current quarter, IQVIA Holdings reported second-quarter results that topped earnings expectations, with adjusted earnings rising 12.1% year over year and revenue increasing 8.7%, prompting management to raise its 2026 revenue, adjusted EBITDA and adjusted diluted earnings guidance. This upgrade was backed by broad-based demand, strong bookings and contributions from acquisitions, all of which reinforced management’s view that business momentum can be sustained into 2027. With...","category":"company","datetime":1787908899,"headline":"How Strong Q2 Beat And Raised 2026 Guidance At IQVIA Holdings (IQV) Has Changed Its Investment Story"}, {"id":141363801,"url":"https://finnhub.io/api/news?id=2442e1edfe615223b69eb20cffdf7b2349955f48d2cd226ea6fb87f61c0f9bbc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1787848214,"headline":"Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?"}, {"id":141202226,"url":"https://finnhub.io/api/news?id=b68daee5cfbfb169797e55d91888f60113a0b2a99cd2acf7556caffc4d5e57e5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"IQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidance and share buybacks support sentiment.","category":"company","datetime":1786540140,"headline":"IQV Stock Gains 42% in 3 Months: Here's What You Should Know"}
raw_source {"id":142062113,"url":"https://finnhub.io/api/news?id=629282c3e6aac776e79975e9844fd0c7943fcd9e03cd3f8babdfbbc2b0d190c3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"NeuroPace (NPCE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1789054204,"headline":"Why Is NeuroPace (NPCE) Down 0.4% Since Last Earnings Report?"}, {"id":142064939,"url":"https://finnhub.io/api/news?id=7d100739ca55d9a6c112a7f2018fc42b45521cd237e053654c4be41a087a8b24","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"IQVIA Holdings has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.","category":"company","datetime":1789048609,"headline":"IQVIA Holdings Stock: Is IQV Outperforming the Health Care Sector?"}, {"id":142029924,"url":"https://finnhub.io/api/news?id=b0593e6550c15efb7052bf63ae754e13470ec3497ea805740b8fa227b3f86737","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"RESEARCH TRIANGLE PARK, N.C., September 09, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the \"Issuer\"), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2034 (the \"Notes\"). The proceeds from the Notes offering will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees an","category":"company","datetime":1788988380,"headline":"IQVIA Announces Pricing of Senior Notes"}, {"id":142024939,"url":"https://finnhub.io/api/news?id=50266b6957d91a307605784def3bb229fa0417b6080bbea7c2fec2000f5d7d0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"RESEARCH TRIANGLE PARK, N.C., September 09, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the \"Issuer\"), intends to raise $2,000,000,000 through an offering of senior notes due 2034 (the \"Notes\").","category":"company","datetime":1788956100,"headline":"IQVIA Announces Offering of Senior Notes"}, {"id":141951092,"url":"https://finnhub.io/api/news?id=93848eb6afb610f535fc89a483e338126f7d28ee25855f7e15a50ffd125b29e4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"The past six months have been a windfall for IQVIA’s shareholders. The company’s stock price has jumped 50%, hitting $267.77 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.","category":"company","datetime":1788877878,"headline":"IQVIA (IQV): Buy, Sell, or Hold Post Q2 Earnings?"}, {"id":141437740,"url":"https://finnhub.io/api/news?id=2a0701d95a1249a51e63482a4752068e9948d2dc1c361845a7d0be8bfedae938","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.","category":"company","datetime":1788534130,"headline":"1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm"}, {"id":141410253,"url":"https://finnhub.io/api/news?id=814e73db5d703af98ad84b037219310746d8c95d98095282138f68b72379680b","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1725655946/image_1725655946.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"IQV","summary":"The S&P 500 gained 2.72% and reached a record high in August, with energy leading the market as crude prices rose. Read more here.","category":"company","datetime":1788496800,"headline":"Software Rebound Extends Moat Index Gains"}, {"id":141404245,"url":"https://finnhub.io/api/news?id=a327a913d3a205b6fb2945a54b45ec71855d612e244b92884d2f649f0039eb6d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"RESEARCH TRIANGLE PARK, N.C., September 03, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster.","category":"company","datetime":1788470100,"headline":"IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster"}, {"id":141403846,"url":"https://finnhub.io/api/news?id=6b9227a9a994e2901b52f76042bd10a151327a8cf995c860e2928c33dbe3d37d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"Veeva raises its fiscal 2027 outlook as Vault CRM adoption, R&D growth and Falcon AI momentum support expanding revenue and profitability.","category":"company","datetime":1788459000,"headline":"VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast"}, {"id":141400604,"url":"https://finnhub.io/api/news?id=d5e1ab45bd4c6513b63d4a79caad09387ba03029f8f90c09b1fb84734e78b5b4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1788449426,"headline":"Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?"}, {"id":141379750,"url":"https://finnhub.io/api/news?id=7b19fa4f8ab4754507dffcc3474d9faec39f32e38f389303e3ccf0a9d99f98ab","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"While most software companies were retreating, Paycom made an aggressive and unconventional bet on itself, and the market delivered a verdict that caught even seasoned analysts off guard.","category":"company","datetime":1788378168,"headline":"This Payroll Software Company Bought Back 20% of Its Shares and the Stock Has Nearly Doubled Since April"}, {"id":141379441,"url":"https://finnhub.io/api/news?id=62e773579e3a62df81afcdad4037a0fd886c9dbd055e0ac4c015a53682f0fe97","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"The market is obsessed with a handful of hyperscalers, but the real story might be the thousands of customers you've never heard of.","category":"company","datetime":1788369887,"headline":"Beyond The Cloud Giants: What Could Power NVIDIA Stock From Here?"}, {"id":141364091,"url":"https://finnhub.io/api/news?id=d36cdb4e0d77330feac0b5cfd3ed05c727f0584ba3c9554ab81131400a40cfa0","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its peers.","category":"company","datetime":1788213160,"headline":"Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment"}, {"id":141355051,"url":"https://finnhub.io/api/news?id=d92b169b63df4d431d6ca4d3e2a910e2a44404564eff749693f603b009075ae3","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/466613278/image_466613278.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"IQV","summary":"Big Pharma hits new 52-week highs on strong Q2 results; explore why some lag and which healthcare ETF offers best income risk/reward. Click for more and the picks.","category":"company","datetime":1788173434,"headline":"Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs"}, {"id":141364092,"url":"https://finnhub.io/api/news?id=e062e495e00253d829c605d40440aad244c900a3d6cfcf9d0ecedb52f3f683d3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"Earlier in the current quarter, IQVIA Holdings reported second-quarter results that topped earnings expectations, with adjusted earnings rising 12.1% year over year and revenue increasing 8.7%, prompting management to raise its 2026 revenue, adjusted EBITDA and adjusted diluted earnings guidance. This upgrade was backed by broad-based demand, strong bookings and contributions from acquisitions, all of which reinforced management’s view that business momentum can be sustained into 2027. With...","category":"company","datetime":1787908899,"headline":"How Strong Q2 Beat And Raised 2026 Guidance At IQVIA Holdings (IQV) Has Changed Its Investment Story"}, {"id":141348579,"url":"https://finnhub.io/api/news?id=d17b53e42200b5ccd779b54e678ee75e7575b5645e80bad7013e99a7f2c183ee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"The real bet is on what lies beyond this year's performance: a pipeline that could change everything.","category":"company","datetime":1787879989,"headline":"Amgen Stock Signals Its Confidence. The Market Agrees."}, {"id":141364093,"url":"https://finnhub.io/api/news?id=a68e10e38175e5a85a197ddb856580dca7d575da5e5c45f1bcd8140f59fadca4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"RESEARCH TRIANGLE PARK, N.C., August 27, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution","category":"company","datetime":1787865300,"headline":"IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare"}, {"id":141363801,"url":"https://finnhub.io/api/news?id=2442e1edfe615223b69eb20cffdf7b2349955f48d2cd226ea6fb87f61c0f9bbc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1787848214,"headline":"Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?"}, {"id":141364097,"url":"https://finnhub.io/api/news?id=66618d43621d274c22fa3d1892453e09ec49fbf5dca3995094610015117a229e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"IQV shares rise 21.7% in a month as data assets, AI-enabled technology and strong cash flow support growth despite liquidity and pricing risks.","category":"company","datetime":1787761020,"headline":"Here's Why You Should Retain IQVIA Stock in Your Portfolio Now"}, {"id":141363380,"url":"https://finnhub.io/api/news?id=0c4a00ea02e52b440c20f3021d96d7fc604ce3633db5909d233d06be4aa5964f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.","category":"company","datetime":1787649764,"headline":"2 Large-Cap Stocks with Exciting Potential and 1 That Underwhelm"}, {"id":141364098,"url":"https://finnhub.io/api/news?id=1db46c71e9a4e70408fe3d151674b8e0eb01f701ecb41898ae7a8c25003ca2ef","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"While traders pointed to external clinical-trial momentum as a major catalyst, Tempus's own recent guidance raise and narrowing losses provided the underlying backdrop.","category":"company","datetime":1787599405,"headline":"What Is Really Moving Tempus AI Stock Right Now?"}, {"id":141364099,"url":"https://finnhub.io/api/news?id=b5d7178df025d845409caa4de3ed7a180818951d8e37581e84ccffe6a667e57f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"VEEV heads into Q2 with Falcon AI, Vault CRM wins and R&D Cloud growth in focus as revenue and EPS estimates point to double-digit gains.","category":"company","datetime":1787592720,"headline":"Can AI Innovation and CRM Wins Boost Veeva Systems' Q2 Results?"}, {"id":141282338,"url":"https://finnhub.io/api/news?id=3046de6b1d88ffc7420634e357f1d3676b81f55e4482259675c37a13227475f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"Charles River's 33.3% monthly surge faces a higher bar as stronger bookings and guidance meet margin pressure and a premium valuation.","category":"company","datetime":1787326620,"headline":"CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?"}, {"id":141282331,"url":"https://finnhub.io/api/news?id=f9bf1ff32f273e8a38b58e32b61a45d16cead1cede2e9b01b5ae33390cddf5eb","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"Despite already outperforming the broader market over the past year, IQVIA continues to enjoy strong backing from Wall Street, with analysts remaining highly optimistic about the stock’s future prospects.","category":"company","datetime":1787316049,"headline":"IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish?"}, {"id":141282336,"url":"https://finnhub.io/api/news?id=41bf54cabe248e75886c89629fa1a0dc8afaee6e4e3c01253ee448bc253827ae","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"RESEARCH TRIANGLE PARK, N.C., August 20, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that its AI-enabled Clinical Decision Support Tool, developed in collaboration with Breakthrough T1D, has won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year.","category":"company","datetime":1787260500,"headline":"IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year"}, {"id":141263724,"url":"https://finnhub.io/api/news?id=79817c6765abca477c158dde61718bc04fe3d602b4fecbff929b0a7fcd1bb05a","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"IQV","summary":"Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.","category":"company","datetime":1787252701,"headline":"Exploring the top movers within the S&P500 index during today's session."}, {"id":141262493,"url":"https://finnhub.io/api/news?id=e35621ca09fce0d3e1edebbfb4c083ea6617d2a571f2e19e5d99d4ad8722292d","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"IQV","summary":"Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.","category":"company","datetime":1787243701,"headline":"Thursday's session: top gainers and losers in the S&P500 index"}, {"id":141261028,"url":"https://finnhub.io/api/news?id=5b54ec56dfde684c05d3723c87da63c116166a04b8bff3d3ea948663950358c1","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2280454849/image_2280454849.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"IQV","summary":"Tempus AI remains a strong buy, driven by its unique flywheel business model and recent validation of its technology via the Personalis acquisition. Learn more about TEM stock here.","category":"company","datetime":1787212800,"headline":"Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance"}, {"id":141282339,"url":"https://finnhub.io/api/news?id=ed5fb101c531497967986eccd9f6e064a8c1bd1727f9d4860f4496c10aa57327","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"RESEARCH TRIANGLE PARK, N.C., August 17, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that it has been ranked No. 1 in Everest Group’s \"Top 50™ Pharmaceutical Technology Providers\" report for 2026.","category":"company","datetime":1787001300,"headline":"IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group"}, {"id":141231125,"url":"https://finnhub.io/api/news?id=20166a2b2acd2263cfdbcc99fc419c59e514054bea615fc73fdbae8d84095aeb","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445262091/image_1445262091.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"IQV","summary":"Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.","category":"company","datetime":1786867596,"headline":"IHF: Healthcare Dashboard For August"}, {"id":141205521,"url":"https://finnhub.io/api/news?id=6832e14b21f0874656f33283932f5bb0210df135957773398747c23a6f14a2bd","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"Well-known pharmaceutical companies such as Merck and Pfizer typically manage this complex process in house. Medpace Holdings which targets oncology, metabolic, cardiology, central nervous system, and anti-infective therapies, raised its 2026 revenue guidance on July’s second-quarter conference call to a midpoint of $2.85 billion, corresponding to a year-over-year increase of 13%. Three months later, Medpace is in the pink: On the heels of second-quarter earnings, the stock is up 14%.","category":"company","datetime":1786622460,"headline":"This Healthcare Services Stock Has 37% Upside"}, {"id":141200512,"url":"https://finnhub.io/api/news?id=00bc77a193caee8506d9c2f7e49efdf6fa5f4b117ad9f052361cece75a324ba4","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"Management raised its full-year forecast, but the market seems to be asking for more than a higher target.","category":"company","datetime":1786562251,"headline":"Amgen Stock And The Price Of A Promise"}, {"id":141202226,"url":"https://finnhub.io/api/news?id=b68daee5cfbfb169797e55d91888f60113a0b2a99cd2acf7556caffc4d5e57e5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"IQV","summary":"IQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidance and share buybacks support sentiment.","category":"company","datetime":1786540140,"headline":"IQV Stock Gains 42% in 3 Months: Here's What You Should Know"}, {"id":141183971,"url":"https://finnhub.io/api/news?id=e4c287cbdc846d32459bf189d2db32e7a5889c8eed8899b4255e36ca7c625a24","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359132436/image_1359132436.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"IQV","summary":"The Moat Index gained 3.96%, outperforming the S&P 500 as its lower mega-cap technology exposure and financials tilt paid off.","category":"company","datetime":1786432380,"headline":"Rotation Away From Tech Lifts Moat Index In July"}
data_source finnhub_news_keyword_model
article_count 6
negative_hits 0
positive_hits 2
recomputed_at_score true
sentiment_score_raw 0.8
source_article_count 34
discarded_article_count 28
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.5 5/110 50% 2.5
資金流 10.8 20/110 54% 10.8
市場環境 6.2 15/110 41.33% 6.2
催化劑 2 20/110 10% 2
風險管理 6.8 10/110 68% 6.8
技術信號 18.9 30/110 63% 18.9
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 5/50
ret_5d -0.0248
max_score 50
max_total 50
raw_total 5
vcp_bonus 0
vol_ratio 1.0493
ret_points 0
vol_points 2
range_ratio 0.8753
volat_points 0
day_range_pct 0.0245
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 3
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Medium
reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.6178
turnoverUsdM 339.4536
liquidityPoints 0.6
volatilityPoints 1
rrPoints 1.4

stopLevels

symbol US.IQV
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 243.8286

strength_details

ma_score 1.5
atr_score 2
rsi_score 2
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1.1
stop_loss_percent 5.2
take_profit_price 272.4441
target_multiplier 1.9
technical_strength 1.78
take_profit_percent 5.9
positionPoints 1.6
stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 5.2357
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.5/5分
資金流分析總分: 10.8/20分
市場環境分析總分: 6.2/15分
催化劑分析: 2/20分
風險管理總分: 6.8/10分
技術信號分析總分: 18.9/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 92.86
atr
atr 6.7357
rule ATR / current price; lower volatility scores higher
score 6
atr_pct 2.62
cci
rule Cursor_18.24 CCI bands
level 平衡
score 6
value 6.18
cmf
rule Cursor_18.24 CMF bands
level 資金流入
score 8
value 0.2951
kdj
d 59.75
j 4.43
k 41.31
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 超賣或超買風險
score 2
value 37.31
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 2
trend 資金流出
value 13153891
recentSlope -359590.9
previousSlope 654150
rsi
value 51.55
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 270.8506
position SAR喺價上
distancePct 5.27
previousTrend 下降
ma50
value 234.0474
macd
macd 8.1704
trend 中性偏多
signal 10.0324
histogram -1.862
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 256.46
position 連續5日>VWAP
consecutiveAbove 35
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.03
score 6
avgVolume 1280570
currentVolume 1319291
derived
ma20 256.308
ma50 234.0474
prevClose 256.98
avgVolume10 1374729
avgVolume20 1280570
changePercent 0.12
avgVolumeForScore 1280570
ma_cross
ma20 256.308
ma50 234.0474
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 255.5285
prevMa50 232.7658
spreadPct 9.51
isVolumeBreakout false
bollinger
lower 237.6658
upper 274.9502
position 上半部
rsi_short
value 48.14
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.03

Raw calculation JSON

 
{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.6178392000714807,
        "turnoverUsdM": 339.45356110709,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.IQV",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 243.8286,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 5.2,
      "take_profit_price": 272.4441,
      "target_multiplier": 1.9,
      "technical_strength": 1.78,
      "take_profit_percent": 5.9
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 5.2356784001429615,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 56.2,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 51.2,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 5
  },
  "market": {
    "ma20": 256.308,
    "ma50": 234.0474,
    "close": 257.3,
    "prevClose": 256.98,
    "avgVolume20": 1280570,
    "volumeRatio": 1.03,
    "changePercent": 0.12
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 5,
    "details": {
      "ret_5d": -0.024787788053365678,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 5,
      "vcp_bonus": 0,
      "vol_ratio": 1.0492673053139752,
      "ret_points": 0,
      "vol_points": 2,
      "range_ratio": 0.8752959287761947,
      "volat_points": 0,
      "day_range_pct": 0.02448499900835589,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 56.2,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.5,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 50,
        "contribution": 2.5
      },
      {
        "raw": 10.8,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 54,
        "contribution": 10.8
      },
      {
        "raw": 6.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 41.33,
        "contribution": 6.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 6.8,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 68,
        "contribution": 6.8
      },
      {
        "raw": 18.9,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 63,
        "contribution": 18.9
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 51.2,
    "details": [
      "基本面分析總分: 2.5/5分",
      "資金流分析總分: 10.8/20分",
      "市場環境分析總分: 6.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 6.8/10分",
      "技術信號分析總分: 18.9/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.5,
      "資金流": 10.8,
      "市場環境": 6.2,
      "情緒分析": 4,
      "技術信號": 18.9,
      "風險管理": 6.8
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.3,
          "marginPoints": 0,
          "turnoverUsdM": 339.45356110709,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 3.2,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.IQV",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 0.8,
            "details": {
              "qqq": {
                "ma20": 716.52749955,
                "ma50": 710.6121986999997,
                "name": "QQQ",
                "close": 708.69,
                "points": 0.4
              },
              "spy": {
                "ma20": 767.5584954500001,
                "ma50": 758.2458016200002,
                "name": "SPY",
                "close": 757.83002,
                "points": 0.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.6178392000714807,
          "atrPoints": 3,
          "cciPoints": 2.4,
          "vixPoints": 0,
          "marketTrendPoints": 0.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 6,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 0.8
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142064939,
                "url": "https://finnhub.io/api/news?id=7d100739ca55d9a6c112a7f2018fc42b45521cd237e053654c4be41a087a8b24",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1789048609,
                "headline": "IQVIA Holdings Stock: Is IQV Outperforming the Health Care Sector?"
              },
              {
                "id": 141951092,
                "url": "https://finnhub.io/api/news?id=93848eb6afb610f535fc89a483e338126f7d28ee25855f7e15a50ffd125b29e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The past six months have been a windfall for IQVIA’s shareholders. The company’s stock price has jumped 50%, hitting $267.77 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1788877878,
                "headline": "IQVIA (IQV): Buy, Sell, or Hold Post Q2 Earnings?"
              },
              {
                "id": 141364091,
                "url": "https://finnhub.io/api/news?id=d36cdb4e0d77330feac0b5cfd3ed05c727f0584ba3c9554ab81131400a40cfa0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its peers.",
                "category": "company",
                "datetime": 1788213160,
                "headline": "Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment"
              },
              {
                "id": 141364092,
                "url": "https://finnhub.io/api/news?id=e062e495e00253d829c605d40440aad244c900a3d6cfcf9d0ecedb52f3f683d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Earlier in the current quarter, IQVIA Holdings reported second-quarter results that topped earnings expectations, with adjusted earnings rising 12.1% year over year and revenue increasing 8.7%, prompting management to raise its 2026 revenue, adjusted EBITDA and adjusted diluted earnings guidance. This upgrade was backed by broad-based demand, strong bookings and contributions from acquisitions, all of which reinforced management’s view that business momentum can be sustained into 2027. With...",
                "category": "company",
                "datetime": 1787908899,
                "headline": "How Strong Q2 Beat And Raised 2026 Guidance At IQVIA Holdings (IQV) Has Changed Its Investment Story"
              },
              {
                "id": 141363801,
                "url": "https://finnhub.io/api/news?id=2442e1edfe615223b69eb20cffdf7b2349955f48d2cd226ea6fb87f61c0f9bbc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787848214,
                "headline": "Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?"
              },
              {
                "id": 141202226,
                "url": "https://finnhub.io/api/news?id=b68daee5cfbfb169797e55d91888f60113a0b2a99cd2acf7556caffc4d5e57e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidance and share buybacks support sentiment.",
                "category": "company",
                "datetime": 1786540140,
                "headline": "IQV Stock Gains 42% in 3 Months: Here's What You Should Know"
              }
            ],
            "raw_source": [
              {
                "id": 142062113,
                "url": "https://finnhub.io/api/news?id=629282c3e6aac776e79975e9844fd0c7943fcd9e03cd3f8babdfbbc2b0d190c3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "NeuroPace (NPCE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1789054204,
                "headline": "Why Is NeuroPace (NPCE) Down 0.4% Since Last Earnings Report?"
              },
              {
                "id": 142064939,
                "url": "https://finnhub.io/api/news?id=7d100739ca55d9a6c112a7f2018fc42b45521cd237e053654c4be41a087a8b24",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA Holdings has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1789048609,
                "headline": "IQVIA Holdings Stock: Is IQV Outperforming the Health Care Sector?"
              },
              {
                "id": 142029924,
                "url": "https://finnhub.io/api/news?id=b0593e6550c15efb7052bf63ae754e13470ec3497ea805740b8fa227b3f86737",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., September 09, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the \"Issuer\"), priced an offering of $2,000,000,000 in aggregate principal amount of senior notes due 2034 (the \"Notes\"). The proceeds from the Notes offering will be used to redeem in full the Issuer’s Senior 5.000% Notes due 2026, to repay a portion of the outstanding indebtedness under the Issuer’s revolving credit facility and to pay fees an",
                "category": "company",
                "datetime": 1788988380,
                "headline": "IQVIA Announces Pricing of Senior Notes"
              },
              {
                "id": 142024939,
                "url": "https://finnhub.io/api/news?id=50266b6957d91a307605784def3bb229fa0417b6080bbea7c2fec2000f5d7d0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., September 09, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the \"Issuer\"), intends to raise $2,000,000,000 through an offering of senior notes due 2034 (the \"Notes\").",
                "category": "company",
                "datetime": 1788956100,
                "headline": "IQVIA Announces Offering of Senior Notes"
              },
              {
                "id": 141951092,
                "url": "https://finnhub.io/api/news?id=93848eb6afb610f535fc89a483e338126f7d28ee25855f7e15a50ffd125b29e4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The past six months have been a windfall for IQVIA’s shareholders. The company’s stock price has jumped 50%, hitting $267.77 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1788877878,
                "headline": "IQVIA (IQV): Buy, Sell, or Hold Post Q2 Earnings?"
              },
              {
                "id": 141437740,
                "url": "https://finnhub.io/api/news?id=2a0701d95a1249a51e63482a4752068e9948d2dc1c361845a7d0be8bfedae938",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
                "category": "company",
                "datetime": 1788534130,
                "headline": "1 Profitable Stock with Solid Fundamentals and 2 That Underwhelm"
              },
              {
                "id": 141410253,
                "url": "https://finnhub.io/api/news?id=814e73db5d703af98ad84b037219310746d8c95d98095282138f68b72379680b",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1725655946/image_1725655946.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "The S&P 500 gained 2.72% and reached a record high in August, with energy leading the market as crude prices rose. Read more here.",
                "category": "company",
                "datetime": 1788496800,
                "headline": "Software Rebound Extends Moat Index Gains"
              },
              {
                "id": 141404245,
                "url": "https://finnhub.io/api/news?id=a327a913d3a205b6fb2945a54b45ec71855d612e244b92884d2f649f0039eb6d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., September 03, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, today announced IQVIA Predictive Clinical Development, an AI-powered approach designed to help life sciences sponsors reduce avoidable delays and bring new therapies to patients up to two years faster.",
                "category": "company",
                "datetime": 1788470100,
                "headline": "IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster"
              },
              {
                "id": 141403846,
                "url": "https://finnhub.io/api/news?id=6b9227a9a994e2901b52f76042bd10a151327a8cf995c860e2928c33dbe3d37d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Veeva raises its fiscal 2027 outlook as Vault CRM adoption, R&D growth and Falcon AI momentum support expanding revenue and profitability.",
                "category": "company",
                "datetime": 1788459000,
                "headline": "VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast"
              },
              {
                "id": 141400604,
                "url": "https://finnhub.io/api/news?id=d5e1ab45bd4c6513b63d4a79caad09387ba03029f8f90c09b1fb84734e78b5b4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "TransMedics (TMDX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788449426,
                "headline": "Why Is TransMedics (TMDX) Up 10.2% Since Last Earnings Report?"
              },
              {
                "id": 141379750,
                "url": "https://finnhub.io/api/news?id=7b19fa4f8ab4754507dffcc3474d9faec39f32e38f389303e3ccf0a9d99f98ab",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "While most software companies were retreating, Paycom made an aggressive and unconventional bet on itself, and the market delivered a verdict that caught even seasoned analysts off guard.",
                "category": "company",
                "datetime": 1788378168,
                "headline": "This Payroll Software Company Bought Back 20% of Its Shares and the Stock Has Nearly Doubled Since April"
              },
              {
                "id": 141379441,
                "url": "https://finnhub.io/api/news?id=62e773579e3a62df81afcdad4037a0fd886c9dbd055e0ac4c015a53682f0fe97",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The market is obsessed with a handful of hyperscalers, but the real story might be the thousands of customers you've never heard of.",
                "category": "company",
                "datetime": 1788369887,
                "headline": "Beyond The Cloud Giants: What Could Power NVIDIA Stock From Here?"
              },
              {
                "id": 141364091,
                "url": "https://finnhub.io/api/news?id=d36cdb4e0d77330feac0b5cfd3ed05c727f0584ba3c9554ab81131400a40cfa0",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its peers.",
                "category": "company",
                "datetime": 1788213160,
                "headline": "Q2 Earnings Roundup: IQVIA (NYSE:IQV) And The Rest Of The Drug Development Inputs & Services Segment"
              },
              {
                "id": 141355051,
                "url": "https://finnhub.io/api/news?id=d92b169b63df4d431d6ca4d3e2a910e2a44404564eff749693f603b009075ae3",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/466613278/image_466613278.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "Big Pharma hits new 52-week highs on strong Q2 results; explore why some lag and which healthcare ETF offers best income risk/reward. Click for more and the picks.",
                "category": "company",
                "datetime": 1788173434,
                "headline": "Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs"
              },
              {
                "id": 141364092,
                "url": "https://finnhub.io/api/news?id=e062e495e00253d829c605d40440aad244c900a3d6cfcf9d0ecedb52f3f683d3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Earlier in the current quarter, IQVIA Holdings reported second-quarter results that topped earnings expectations, with adjusted earnings rising 12.1% year over year and revenue increasing 8.7%, prompting management to raise its 2026 revenue, adjusted EBITDA and adjusted diluted earnings guidance. This upgrade was backed by broad-based demand, strong bookings and contributions from acquisitions, all of which reinforced management’s view that business momentum can be sustained into 2027. With...",
                "category": "company",
                "datetime": 1787908899,
                "headline": "How Strong Q2 Beat And Raised 2026 Guidance At IQVIA Holdings (IQV) Has Changed Its Investment Story"
              },
              {
                "id": 141348579,
                "url": "https://finnhub.io/api/news?id=d17b53e42200b5ccd779b54e678ee75e7575b5645e80bad7013e99a7f2c183ee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "The real bet is on what lies beyond this year's performance: a pipeline that could change everything.",
                "category": "company",
                "datetime": 1787879989,
                "headline": "Amgen Stock Signals Its Confidence. The Market Agrees."
              },
              {
                "id": 141364093,
                "url": "https://finnhub.io/api/news?id=a68e10e38175e5a85a197ddb856580dca7d575da5e5c45f1bcd8140f59fadca4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., August 27, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced it received recognition this year from multiple independent industry awards programs for its use of AI to help healthcare and life sciences organizations improve decisions, strengthen regulated workflows, protect patient privacy and optimize clinical trial execution",
                "category": "company",
                "datetime": 1787865300,
                "headline": "IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare"
              },
              {
                "id": 141363801,
                "url": "https://finnhub.io/api/news?id=2442e1edfe615223b69eb20cffdf7b2349955f48d2cd226ea6fb87f61c0f9bbc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA (IQV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1787848214,
                "headline": "Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?"
              },
              {
                "id": 141364097,
                "url": "https://finnhub.io/api/news?id=66618d43621d274c22fa3d1892453e09ec49fbf5dca3995094610015117a229e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQV shares rise 21.7% in a month as data assets, AI-enabled technology and strong cash flow support growth despite liquidity and pricing risks.",
                "category": "company",
                "datetime": 1787761020,
                "headline": "Here's Why You Should Retain IQVIA Stock in Your Portfolio Now"
              },
              {
                "id": 141363380,
                "url": "https://finnhub.io/api/news?id=0c4a00ea02e52b440c20f3021d96d7fc604ce3633db5909d233d06be4aa5964f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.",
                "category": "company",
                "datetime": 1787649764,
                "headline": "2 Large-Cap Stocks with Exciting Potential and 1 That Underwhelm"
              },
              {
                "id": 141364098,
                "url": "https://finnhub.io/api/news?id=1db46c71e9a4e70408fe3d151674b8e0eb01f701ecb41898ae7a8c25003ca2ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "While traders pointed to external clinical-trial momentum as a major catalyst, Tempus's own recent guidance raise and narrowing losses provided the underlying backdrop.",
                "category": "company",
                "datetime": 1787599405,
                "headline": "What Is Really Moving Tempus AI Stock Right Now?"
              },
              {
                "id": 141364099,
                "url": "https://finnhub.io/api/news?id=b5d7178df025d845409caa4de3ed7a180818951d8e37581e84ccffe6a667e57f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "VEEV heads into Q2 with Falcon AI, Vault CRM wins and R&D Cloud growth in focus as revenue and EPS estimates point to double-digit gains.",
                "category": "company",
                "datetime": 1787592720,
                "headline": "Can AI Innovation and CRM Wins Boost Veeva Systems' Q2 Results?"
              },
              {
                "id": 141282338,
                "url": "https://finnhub.io/api/news?id=3046de6b1d88ffc7420634e357f1d3676b81f55e4482259675c37a13227475f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Charles River's 33.3% monthly surge faces a higher bar as stronger bookings and guidance meet margin pressure and a premium valuation.",
                "category": "company",
                "datetime": 1787326620,
                "headline": "CRL Jumps 33.3% in the Past Month: Can This Strong Rally Keep Running?"
              },
              {
                "id": 141282331,
                "url": "https://finnhub.io/api/news?id=f9bf1ff32f273e8a38b58e32b61a45d16cead1cede2e9b01b5ae33390cddf5eb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Despite already outperforming the broader market over the past year, IQVIA continues to enjoy strong backing from Wall Street, with analysts remaining highly optimistic about the stock’s future prospects.",
                "category": "company",
                "datetime": 1787316049,
                "headline": "IQVIA Holdings Stock Outlook: Is Wall Street Bullish or Bearish?"
              },
              {
                "id": 141282336,
                "url": "https://finnhub.io/api/news?id=41bf54cabe248e75886c89629fa1a0dc8afaee6e4e3c01253ee448bc253827ae",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., August 20, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that its AI-enabled Clinical Decision Support Tool, developed in collaboration with Breakthrough T1D, has won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year.",
                "category": "company",
                "datetime": 1787260500,
                "headline": "IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year"
              },
              {
                "id": 141263724,
                "url": "https://finnhub.io/api/news?id=79817c6765abca477c158dde61718bc04fe3d602b4fecbff929b0a7fcd1bb05a",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights.",
                "category": "company",
                "datetime": 1787252701,
                "headline": "Exploring the top movers within the S&P500 index during today's session."
              },
              {
                "id": 141262493,
                "url": "https://finnhub.io/api/news?id=e35621ca09fce0d3e1edebbfb4c083ea6617d2a571f2e19e5d99d4ad8722292d",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "IQV",
                "summary": "Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1787243701,
                "headline": "Thursday's session: top gainers and losers in the S&P500 index"
              },
              {
                "id": 141261028,
                "url": "https://finnhub.io/api/news?id=5b54ec56dfde684c05d3723c87da63c116166a04b8bff3d3ea948663950358c1",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2280454849/image_2280454849.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "Tempus AI remains a strong buy, driven by its unique flywheel business model and recent validation of its technology via the Personalis acquisition. Learn more about TEM stock here.",
                "category": "company",
                "datetime": 1787212800,
                "headline": "Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance"
              },
              {
                "id": 141282339,
                "url": "https://finnhub.io/api/news?id=ed5fb101c531497967986eccd9f6e064a8c1bd1727f9d4860f4496c10aa57327",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "RESEARCH TRIANGLE PARK, N.C., August 17, 2026--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that it has been ranked No. 1 in Everest Group’s \"Top 50™ Pharmaceutical Technology Providers\" report for 2026.",
                "category": "company",
                "datetime": 1787001300,
                "headline": "IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group"
              },
              {
                "id": 141231125,
                "url": "https://finnhub.io/api/news?id=20166a2b2acd2263cfdbcc99fc419c59e514054bea615fc73fdbae8d84095aeb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445262091/image_1445262091.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.",
                "category": "company",
                "datetime": 1786867596,
                "headline": "IHF: Healthcare Dashboard For August"
              },
              {
                "id": 141205521,
                "url": "https://finnhub.io/api/news?id=6832e14b21f0874656f33283932f5bb0210df135957773398747c23a6f14a2bd",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Well-known pharmaceutical companies such as  Merck  and  Pfizer  typically manage this complex process in house.  Medpace Holdings  which targets oncology, metabolic, cardiology, central nervous system, and anti-infective therapies, raised its 2026 revenue guidance on July’s second-quarter conference call to a midpoint of $2.85 billion, corresponding to a year-over-year increase of 13%.  Three months later, Medpace is in the pink: On the heels of second-quarter earnings, the stock is up 14%.",
                "category": "company",
                "datetime": 1786622460,
                "headline": "This Healthcare Services Stock Has 37% Upside"
              },
              {
                "id": 141200512,
                "url": "https://finnhub.io/api/news?id=00bc77a193caee8506d9c2f7e49efdf6fa5f4b117ad9f052361cece75a324ba4",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "Management raised its full-year forecast, but the market seems to be asking for more than a higher target.",
                "category": "company",
                "datetime": 1786562251,
                "headline": "Amgen Stock And The Price Of A Promise"
              },
              {
                "id": 141202226,
                "url": "https://finnhub.io/api/news?id=b68daee5cfbfb169797e55d91888f60113a0b2a99cd2acf7556caffc4d5e57e5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "IQV",
                "summary": "IQVIA shares jump 41.5% in three months as record R&DS bookings, a solid backlog, raised 2026 guidance and share buybacks support sentiment.",
                "category": "company",
                "datetime": 1786540140,
                "headline": "IQV Stock Gains 42% in 3 Months: Here's What You Should Know"
              },
              {
                "id": 141183971,
                "url": "https://finnhub.io/api/news?id=e4c287cbdc846d32459bf189d2db32e7a5889c8eed8899b4255e36ca7c625a24",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1359132436/image_1359132436.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "IQV",
                "summary": "The Moat Index gained 3.96%, outperforming the S&P 500 as its lower mega-cap technology exposure and financials tilt paid off.",
                "category": "company",
                "datetime": 1786432380,
                "headline": "Rotation Away From Tech Lifts Moat Index In July"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 6,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.8,
            "source_article_count": 34,
            "discarded_article_count": 28
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.9,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(17.4%→7.2%)；跌縮量(近10日4日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 1321793.3333333333,
              "down_days": 6,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 1370010,
              "avg_vol_20": 1257345,
              "avg_vol_30": 1321793.3333333333,
              "range_pct_10": 0.07244458112882159,
              "range_pct_20": 0.1478429905885344,
              "range_pct_30": 0.1735328477859637,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.036478218985318,
              "dist_to_20d_high": 0.053348051999560414,
              "down_shrink_days": 4,
              "breakout_level_20d": 271.79999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.4174689809630457
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0.4,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "一般",
        "items": {
          "position": {
            "score": 1.6,
            "details": {
              "atrPct": 2.6178392000714807,
              "turnoverUsdM": 339.45356110709,
              "liquidityPoints": 0.6,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.IQV",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 243.8286,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 5.2,
            "take_profit_price": 272.4441,
            "target_multiplier": 1.9,
            "technical_strength": 1.78,
            "take_profit_percent": 5.9
          },
          "positionPoints": 1.6,
          "stopLossPoints": 1.8,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 5.2356784001429615,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.IQV",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 6.7357,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.62
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 6.18
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "資金流入",
      "score": 8,
      "value": 0.2951
    },
    "kdj": {
      "d": 59.75,
      "j": 4.43,
      "k": 41.31,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 37.31
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 13153891,
      "recentSlope": -359590.9,
      "previousSlope": 654150
    },
    "rsi": 51.55,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 270.8506,
      "position": "SAR喺價上",
      "distancePct": 5.27,
      "previousTrend": "下降"
    },
    "ma50": 234.0474,
    "macd": {
      "macd": 8.170412408927177,
      "trend": "中性偏多",
      "signal": 10.032421791969941,
      "histogram": -1.8620093830427642
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 256.46,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 35
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.03,
      "score": 6,
      "avgVolume": 1280570,
      "currentVolume": 1319291
    },
    "derived": {
      "ma20": 256.308,
      "ma50": 234.0474,
      "prevClose": 256.98,
      "avgVolume10": 1374729,
      "avgVolume20": 1280570,
      "changePercent": 0.12,
      "avgVolumeForScore": 1280570
    },
    "ma_cross": {
      "ma20": 256.308,
      "ma50": 234.0474,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 255.5285,
      "prevMa50": 232.7658,
      "spreadPct": 9.51,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 237.6658,
      "upper": 274.9502,
      "position": "上半部"
    },
    "rsi_short": 48.14,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.03
    }
  }
}

Raw metrics JSON

 
{
  "close": 257.3,
  "volume": 1319291,
  "changePercent": 0.12
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.